Hanson Wade Group

⏰Today is your FINAL CHANCE to secure our highest discounts of up to $1,100 for the CDD for Biologics Summit!  𝗦𝗲𝗲 𝗮 𝗯𝗿𝗲𝗮𝗸𝗱𝗼𝘄𝗻 𝗼𝗳 𝘁𝗵𝗲 𝘀𝗮𝘃𝗶𝗻𝗴𝘀 𝗼𝗻 𝗼𝗳𝗳𝗲𝗿 𝗶𝗻 𝘁𝗵𝗲 𝗲𝘃𝗲𝗻𝘁 𝗽𝗿𝗼𝗴𝗿𝗮𝗺 - https://ter.li/f4n6x2 The 9th Computational Drug Development for Biologics Summit is the only industry-focused event dedicated to leveraging these advancements to guide decision-making and expedite biologic drug discovery and development. Join us and don’t miss this opportunity to explore the full potential of computational tools across the biologic development pipeline and learn how to seamlessly integrate AI tools to expedite the process. #CDD

We are proud to highlight 𝗚𝗲𝗻𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗡𝗲𝘁 net as another media partner for the 𝟲𝘁𝗵 𝗠𝗮𝗰𝗿𝗼𝗽𝗵𝗮𝗴𝗲-𝗗𝗶𝗿𝗲𝗰𝘁𝗲𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗦𝘂𝗺𝗺𝗶𝘁!   Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and serves as a network for the exchange of gene therapy information and breaking news. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. - https://lnkd.in/eXzKS55u   Now associated with this groundbreaking networking and learning forum, we're set to 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺 𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵𝗲𝘀 𝘁𝗼 𝗺𝗮𝗰𝗿𝗼𝗽𝗵𝗮𝗴𝗲-𝗱𝗶𝗿𝗲𝗰𝘁𝗲𝗱 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 and unlock 𝗿𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗮𝗿𝘆 𝗮𝗻𝗱 𝗹𝘂𝗰𝗿𝗮𝘁𝗶𝘃𝗲 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀 in 𝗼𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗮𝗻𝗱 𝗯𝗲𝘆𝗼𝗻𝗱.   𝗚𝗿𝗮𝗯 𝘆𝗼𝘂𝗿 𝗳𝘂𝗹𝗹 𝗮𝗴𝗲𝗻𝗱𝗮 𝗵𝗲𝗿𝗲 - https://ter.li/9mldwy   #MacrophageDirectedTherapiesSummit 

Speaker Spotlight Series - Factor Bioscience Inc.🔦 Ahead of the 4th mRNA-Based Therapeutics Summit in just two weeks' time, we caught up with Matt Angel, Chief Executive Officer at Factor Bioscience. Matt will be presenting on "Harnessing mRNA Technology to Unlock Cell Engineering Applications Against Solid Tumors", introducing Factor's proprietary platform applying mRNA to in vivo cell engineering therapeutics, transforming CAR-T cells in vivo to target solid tumors, and expressing gene editing proteins in vivo to turn "cold" tumors into "hot" tumors. Thanks for taking the time to chat to us, Matt! See the full agenda here: https://ter.li/hjpwac #mRNA #RNA #WorldRNA #mRNASummit #mRNATherapeutics #mRNAVaccines

Iovance Biotherapeutics, Inc.'s Amtagvi has been approved but what is next for TIL Therapies? Join us this October at the 6th Annual TIL Therapies Summit to expand TIL treatment beyond melanoma. In our agenda you will find: 🗣 KSQ Therapeutics, Inc.'s discussion on KSQ-001EX which was recently dosed in the first patient. 💊 Iovance Biotherapeutics, Inc.'s presentation on their next generation TIL candidates. 💰 Alliance for Regenerative Medicine's panel discussion on preparing TIL treatment for commercialization. 📈 Marble Therapeutics's talk on current innovations in cell culture methods for effective TIL expansion. Discover the full session descriptions ➡ https://ter.li/zi4url With brand-new 2 tracked agenda, this summit will provide your entire team with the cutting-edge insights and tools needed to streamline manufacturing, enhance product potency, and optimize patient treatment!  Secure your pass ➡ https://ter.li/xk9w4s

Less than 3 days until early bird discounts end! Register now and attend the The 5th Commercializing Flow Chemistry Summit, saving up to $1,100 on full price tickets! https://ter.li/h0ch3a This event marks a pivotal year, introducing a significant shift in content to address the evolving needs of the pharmaceutical manufacturing industry. This summit zeroes in on advanced scale-up capabilities and stakeholder engagement strategies, responding to a market that is rapidly expanding and forecasted to reach US $4.6 billion by 2032. Don't be left behind. Register now for essential learnings: https://ter.li/h0ch3a

❓ Want to know more about Spatial Biology in 2024 ❓ https://ter.li/xvwqx1 Download our brand-new report for more info on: 📈 Estimated Market Size and Growth Predictions 💡 Problems and Solutions 🔑 Key Industry Players and much more... https://ter.li/xvwqx1

❗️ Exciting News❗️   We're thrilled to announce another powerhouse sponsor for the 𝟲𝘁𝗵 𝗠𝗮𝗰𝗿𝗼𝗽𝗵𝗮𝗴𝗲-𝗗𝗶𝗿𝗲𝗰𝘁𝗲𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗦𝘂𝗺𝗺𝗶𝘁! This growing partnership panel highlights the unmatched opportunities and prestige this event offers.   𝗘𝘅𝗽𝗹𝗼𝗿𝗲 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗴𝗲𝗻𝗱𝗮 - https://ter.li/zh9tqa   iOmx Therapeutics AG is a clinical-stage biotech company that harnesses deep tumour immuno-biology insights along with its proprietary iOTarg™ target screening platform, to generate novel treatments for the most prevalent solid tumour indications.   𝘙𝘦𝘢𝘥𝘺 𝘵𝘰 𝘨𝘢𝘪𝘯 𝘧𝘪𝘳𝘴𝘵-𝘩𝘢𝘯𝘥 𝘬𝘯𝘰𝘸𝘭𝘦𝘥𝘨𝘦 𝘢𝘯𝘥 𝘭𝘦𝘢𝘳𝘯 𝘢𝘯𝘥 𝘯𝘦𝘵𝘸𝘰𝘳𝘬 𝘸𝘪𝘵𝘩 𝘵𝘰𝘱 𝘪𝘯𝘴𝘵𝘪𝘵𝘶𝘵𝘪𝘰𝘯𝘴 𝘭𝘪𝘬𝘦 𝘾𝙖𝙧𝙞𝙨𝙢𝙖 𝙏𝙝𝙚𝙧𝙖𝙥𝙚𝙪𝙩𝙞𝙘𝙨, 𝙃𝙖𝙧𝙫𝙖𝙧𝙙 𝙈𝙚𝙙𝙞𝙘𝙖𝙡 𝙎𝙘𝙝𝙤𝙤𝙡, 𝙅𝙤𝙝𝙣𝙨 𝙃𝙤𝙥𝙠𝙞𝙣𝙨 𝙎𝙘𝙝𝙤𝙤𝙡 𝙤𝙛 𝙈𝙚𝙙𝙞𝙘𝙞𝙣𝙚, and more?   Look no further than this unparalleled gathering, where you can also forge strategic partnerships with our full sponsorship panel.   𝗟𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲 𝗮𝗯𝗼𝘂𝘁 𝘁𝗵𝗶𝘀 𝗺𝗲𝗲𝘁𝗶𝗻𝗴 - https://ter.li/zh9tqa   #MacrophageDirectedTherapiesSummit

❗️Announcement❗️   We're thrilled to introduce So-ching Brazer, Ph.D., RAC, Executive Director, Regulatory Affairs CMC from Adicet Bio, Inc, as the newest addition to our expert speaker faculty!   𝗘𝘅𝗽𝗹𝗼𝗿𝗲 𝗦𝗼-𝗖𝗵𝗶𝗻𝗴'𝘀 𝘀𝗲𝘀𝘀𝗶𝗼𝗻 𝗶𝗻 𝗺𝗼𝗿𝗲 𝗱𝗲𝘁𝗮𝗶𝗹 𝗯𝘆 𝗱𝗼𝘄𝗻𝗹𝗼𝗮𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗴𝗲𝗻𝗱𝗮 - https://ter.li/5rd56b   The 𝗖𝗲𝗹𝗹 & 𝗚𝗲𝗻𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗔𝗳𝗳𝗮𝗶𝗿𝘀 𝗦𝘂𝗺𝗺𝗶𝘁 is a truly unique forum, dedicated to navigating the most perplexing regulatory hurdles that many are faced with in the cell and gene therapy space.   💼 Now's your chance to network with regulatory experts from 𝗔𝗱𝗶𝗰𝗲𝘁 𝗕𝗶𝗼, 𝗢𝗿𝗰𝗵𝗮𝗿𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀, 𝗔𝘀𝘁𝗿𝗮𝗭𝗲𝗻𝗲𝗰𝗮, 𝗕𝗿𝗶𝘀𝘁𝗼𝗹 𝗠𝘆𝗲𝗿𝘀 𝗦𝗾𝘂𝗶𝗯𝗯, and more while gaining valuable guidance on 𝗻𝗲𝗴𝗼𝘁𝗶𝗮𝘁𝗶𝗻𝗴 𝘄𝗶𝘁𝗵 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗯𝗼𝗱𝗶𝗲𝘀, 𝗶𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀, and 𝗜𝗡𝗗/𝗕𝗟𝗔 𝗮𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗽𝗿𝗼𝗰𝗲𝘀𝘀𝗲𝘀.🌍   𝗙𝗶𝗻𝗱 𝗼𝘂𝘁 𝗺𝗼𝗿𝗲 𝗵𝗲𝗿𝗲 - https://ter.li/5rd56b   #CellAndGeneTherapyRegulatoryAffairsSummit

We are excited to open up 3rd Advancing Construction Decarbonization with the announcement from our speaker from Google Noah Goldstein, Ph.D. about the release of the iMasons Climate Accord Open Letter, supported by Amazon Web Services (AWS), Digital Realty, Google, Meta, Microsoft and Schneider Electric. The letter calls on all suppliers serving data centers to support greater transparency in Scope 3 emissions as part of broader efforts to reduce the industry’s carbon footprint. We’ll be discussing this and more important initiatives further at the conference in the next 2 days, so stay tuned for more exciting announcements! #AdvancingConstructionDecarbonization24 #AdvancingConstruction #embodiedcarbon #datacenters #scope3emissions #Google

Are regulatory bottlenecks impacting your ROI? Then look no further than the 3rd Cell Therapy Analytical Development Summit Europe, returning to London this September. With Resolution Therapeutics, Johnson & Johnson, GSK and more confirmed to speak, this meeting will provide you with the tools needed to face cell therapy approval challenges head on. 💰 Understand the cost-saving benefits of ddPCR technology with GLP-SR Tiget. 💵 Craft cost-effective potency assays with Resolution Therapeutics. 📈 Streamline your regulatory compliance with Johnson & Johnson. Discover all our cutting-edge sessions here: https://ter.li/fg45ak With time ticking away until we return to London, grab your pass whilst our best possible prices are still available! Secure your £350 saving now: https://ter.li/pxyfzp